Tudor Investment Corp’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.17M | Sell |
196,563
-10
| -0% | -$110 | ﹤0.01% | 865 |
|
|
2025
Q1 | $1.76M | Sell |
196,573
-5
| -0% | -$45 | 0.01% | 852 |
|
|
2024
Q4 | $1.85M | Hold |
196,578
| – | – | 0.01% | 796 |
|
|
2024
Q3 | $1.58M | Buy |
196,578
+2,810
| +1% | +$22.6K | 0.01% | 855 |
|
|
2024
Q2 | $1.64M | Buy |
193,768
+16,156
| +9% | +$137K | 0.01% | 796 |
|
|
2024
Q1 | $1.59M | Buy |
177,612
+167,529
| +1,661% | +$1.5M | 0.01% | 748 |
|
|
2023
Q4 | $113K | Sell |
10,083
-97,665
| -91% | -$1.1M | ﹤0.01% | 1371 |
|
|
2023
Q3 | $930K | Sell |
107,748
-13,918
| -11% | -$120K | 0.01% | 931 |
|
|
2023
Q2 | $1.26M | Buy |
121,666
+13,031
| +12% | +$135K | 0.02% | 821 |
|
|
2023
Q1 | $1.18M | Buy |
108,635
+15,201
| +16% | +$165K | 0.02% | 844 |
|
|
2022
Q4 | $1.05M | Buy |
+93,434
| New | +$1.05M | 0.02% | 829 |
|
|
2022
Q3 | – | Sell |
-103,280
| Closed | -$936K | – | 1975 |
|
|
2022
Q2 | $936K | Buy |
103,280
+71,364
| +224% | +$647K | 0.02% | 844 |
|
|
2022
Q1 | $305K | Sell |
31,916
-141,498
| -82% | -$1.35M | 0.01% | 1272 |
|
|
2021
Q4 | $1.92M | Buy |
173,414
+121,705
| +235% | +$1.34M | 0.03% | 612 |
|
|
2021
Q3 | $383K | Buy |
+51,709
| New | +$383K | 0.01% | 1227 |
|
|
2015
Q3 | – | Sell |
-27,800
| Closed | -$362K | – | 1669 |
|
|
2015
Q2 | $362K | Buy |
+27,800
| New | +$362K | 0.01% | 955 |
|